X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2805) 2805
Publication (147) 147
Book Review (142) 142
Magazine Article (15) 15
Conference Proceeding (3) 3
Book Chapter (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2673) 2673
atorvastatin calcium (2427) 2427
humans (2108) 2108
male (1971) 1971
female (1510) 1510
heptanoic acids - administration & dosage (1384) 1384
pyrroles - administration & dosage (1351) 1351
middle aged (1237) 1237
heptanoic acids - therapeutic use (1143) 1143
pyrroles - therapeutic use (1103) 1103
atorvastatin (1090) 1090
statins (890) 890
aged (884) 884
heptanoic acids - pharmacology (859) 859
animals (823) 823
pyrroles - pharmacology (753) 753
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (749) 749
adult (670) 670
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (648) 648
cholesterol (613) 613
treatment outcome (603) 603
cardiac & cardiovascular systems (600) 600
pharmacology & pharmacy (563) 563
cholesterol, ldl - blood (499) 499
abridged index medicus (498) 498
anticholesteremic agents - administration & dosage (486) 486
simvastatin (484) 484
dose-response relationship, drug (448) 448
anticholesteremic agents - therapeutic use (438) 438
rats (437) 437
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (427) 427
heptanoic acids - adverse effects (377) 377
pyrroles - adverse effects (370) 370
hypercholesterolemia - drug therapy (362) 362
atherosclerosis (350) 350
drug therapy, combination (343) 343
pravastatin (331) 331
double-blind method (330) 330
antilipemic agents (315) 315
drug therapy (311) 311
peripheral vascular disease (305) 305
risk factors (297) 297
cholesterol - blood (295) 295
hypercholesterolemia (291) 291
time factors (288) 288
lipids (269) 269
prevention (248) 248
mice (245) 245
prospective studies (242) 242
triglycerides - blood (238) 238
inflammation (236) 236
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (232) 232
simvastatin - administration & dosage (222) 222
medicine, general & internal (219) 219
therapy (218) 218
analysis (217) 217
cardiovascular (217) 217
disease (216) 216
lipids - blood (215) 215
anticholesteremic agents - pharmacology (213) 213
risk (212) 212
cardiovascular disease (209) 209
statin (209) 209
research (206) 206
drug administration schedule (205) 205
coronary-heart-disease (202) 202
follow-up studies (199) 199
cholesterol, hdl - blood (196) 196
simvastatin - therapeutic use (195) 195
c-reactive protein (193) 193
hypercholesterolemia - blood (188) 188
disease models, animal (187) 187
care and treatment (181) 181
hyperlipidemias - drug therapy (179) 179
rosuvastatin calcium (177) 177
heptanoic acids - pharmacokinetics (175) 175
drug interactions (168) 168
oxidative stress (168) 168
expression (166) 166
aged, 80 and over (163) 163
myocardial-infarction (163) 163
pyrroles - pharmacokinetics (163) 163
statin therapy (163) 163
rats, wistar (161) 161
cardiology (159) 159
anticholesteremic agents - adverse effects (157) 157
cardiovascular diseases - prevention & control (154) 154
cardiovascular-disease (152) 152
coa reductase inhibitors (151) 151
coronary heart disease (151) 151
safety (151) 151
efficacy (145) 145
rats, sprague-dawley (145) 145
cardiovascular agents (141) 141
dosage and administration (136) 136
rosuvastatin (135) 135
administration, oral (132) 132
biomarkers - blood (131) 131
nitric-oxide synthase (130) 130
pravastatin - administration & dosage (128) 128
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2658) 2658
German (40) 40
Russian (37) 37
Chinese (16) 16
Spanish (14) 14
Japanese (11) 11
French (9) 9
Hungarian (6) 6
Italian (6) 6
Polish (4) 4
Swedish (4) 4
Ukrainian (4) 4
Czech (3) 3
Danish (2) 2
Lithuanian (2) 2
Norwegian (2) 2
Croatian (1) 1
Dutch (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 08/2015, Volume 100, Issue 8, pp. 3140 - 3148
Journal Article
BMJ : British Medical Journal, ISSN 0959-8138, 5/2013, Volume 346, Issue 7911, pp. 14 - 14
Objective To examine the risk of new onset diabetes among patients treated with different HMG-CoA reductase inhibitors (statins).Design Population based cohort... 
RESEARCH | Secondary prevention | Depopulation | Population growth | Diabetes | Older adults | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | THERAPY | EVENTS | CHOLESTEROL | CORONARY | DISEASE | PREVENTION | RANDOMIZED CONTROLLED-TRIAL | MELLITUS | ATORVASTATIN | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Simvastatin - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Male | Fluorobenzenes - administration & dosage | Heptanoic Acids - adverse effects | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Dose-Response Relationship, Drug | Pyrroles - administration & dosage | Cardiovascular Diseases - epidemiology | Heptanoic Acids - administration & dosage | Pravastatin - adverse effects | Pyrroles - adverse effects | Diabetes Mellitus, Type 2 - etiology | Female | Retrospective Studies | Odds Ratio | Dyslipidemias - drug therapy | Pyrimidines - administration & dosage | Simvastatin - administration & dosage | Proportional Hazards Models | Rosuvastatin Calcium | Treatment Outcome | Atorvastatin Calcium | Dyslipidemias - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Pravastatin - administration & dosage | Ontario - epidemiology | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Aged | Fluorobenzenes - adverse effects | Diabetes Mellitus, Type 2 - chemically induced | Population Surveillance | Sulfonamides - administration & dosage | Cohort Studies | Inhibitor drugs | Risk assessment | Statins | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
JAMA, ISSN 0098-7484, 05/2014, Volume 311, Issue 18, pp. 1870 - 1882
Journal Article
Endocrinology, ISSN 0013-7227, 05/2005, Volume 146, Issue 5, pp. 2255 - 2264
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 08/2009, Volume 86, Issue 2, pp. 197 - 203
The ABCG2 c.421C>A single‐nucleotide polymorphism (SNP) was determined in 660 healthy Finnish volunteers, of whom 32 participated in a pharmacokinetic... 
BCRP GENE POLYMORPHISMS | ACID | HUMAN PLASMA | SLCO1B1 POLYMORPHISM | LACTONE FORMS | TRANSPORTER ABCG2 | PHARMACOLOGY & PHARMACY | INDUCED MYOPATHY | CANCER RESISTANCE PROTEIN | SINGLE NUCLEOTIDE POLYMORPHISMS | P-GLYCOPROTEIN | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Fluorobenzenes - pharmacokinetics | Pyrroles - pharmacokinetics | Pyrroles - urine | Area Under Curve | Drug Resistance, Multiple | Pyrimidines - blood | Heptanoic Acids - pharmacokinetics | Humans | Male | Reference Values | Fluorobenzenes - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Sulfonamides - blood | ATP-Binding Cassette Transporters - genetics | Sulfonamides - urine | Pyrroles - administration & dosage | Fluorobenzenes - urine | Heptanoic Acids - administration & dosage | Adult | Female | Fluorobenzenes - blood | Neoplasm Proteins - genetics | European Continental Ancestry Group - genetics | Pyrimidines - administration & dosage | Rosuvastatin Calcium | Genotype | Linear Models | Pyrroles - blood | Sulfonamides - pharmacokinetics | Cross-Over Studies | Atorvastatin Calcium | Anticholesteremic Agents - pharmacokinetics | Heptanoic Acids - urine | Finland | Pyrimidines - pharmacokinetics | Polymorphism, Single Nucleotide | Pyrimidines - urine | Heptanoic Acids - blood | Sulfonamides - administration & dosage | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 20, pp. 1891 - 1900
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2015, Volume 66, Issue 5, pp. 495 - 507
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2005, Volume 352, Issue 1, pp. 20 - 28
Statin therapy lowers not only low-density lipoprotein (LDL) cholesterol levels, but also levels of C-reactive protein (CRP), a marker of inflammation. This... 
MEDICINE, GENERAL & INTERNAL | DENSITY-LIPOPROTEIN CHOLESTEROL | HEART-DISEASE | TREATMENT PANEL-III | INFLAMMATION | CARDIOVASCULAR-DISEASE | RISK | ACUTE CORONARY SYNDROMES | UNSTABLE ANGINA | PRAVASTATIN | PRIMARY PREVENTION | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Myocardial Infarction - blood | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Secondary Prevention | Coronary Disease - mortality | Incidence | C-Reactive Protein - metabolism | Pyrroles - administration & dosage | Heptanoic Acids - administration & dosage | Cholesterol, LDL - blood | Female | C-Reactive Protein - drug effects | Pyrroles - therapeutic use | Pravastatin - therapeutic use | Heptanoic Acids - pharmacology | Pravastatin - pharmacology | Coronary Disease - blood | Risk Factors | Proportional Hazards Models | Cholesterol, LDL - drug effects | Fluoroquinolones - therapeutic use | Biomarkers - blood | Atorvastatin Calcium | Coronary Disease - prevention & control | Pyrroles - pharmacology | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Myocardial Infarction - drug therapy | Pravastatin - administration & dosage | Anticholesteremic Agents - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Myocardial Infarction - prevention & control | Anticholesteremic Agents - pharmacology | Cardiovascular disease | Heart attacks | Cholesterol | Statins | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2005, Volume 352, Issue 14, pp. 1425 - 1435
Journal Article